New heart failure guidelines add another type of meds to treatment recommendations

New heart failure guidelines add another type of meds to treatment recommendations

Invalid Date by CNN.com - RSS Channel - App Health Section

Key Facts

  • 01:31 - Source: CNN Staying social can improve your heart health CNN — The American College of Cardiology, the American Heart Association and the Heart Failure Society of America released new guidelines Friday that add a fourth class of medication to the recommended treatment plan for people who have a condition called heart failure with reduced ejection fraction.
  • The new guidelines advise prescribers to add SGLT2 inhibitors as the fourth type of medication for people who have heart failure with reduced ejection fraction.
  • The new recommendations were based off two clinical trials that found that people with heart failure with reduced ejection fraction who took the SGLT2 inhibitors dapagliflozin and empagliflozin lived longer.
  • For the first time, the guidelines also provide treatment recommendations for people who have heart failure with ejection fractions between 41% and 49%, considered “mildly reduced ejection fractions,” and people who have ejection fractions of 50% and above, called preserved ejection fraction.

Click To Read Full Article

PERCENT
PERSON
GROUP
GEOGRAPHY
MISCELLANEOUS

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?